Sign in or register to see full information and data.

Studies / CAVD 384


Study information

Grant Affiliation:Shattock: Novel Antigens for Mucosal Protection
Strategy:Protein & peptide vaccines
Study Type:Pre-Clinical NHP
Species:Cynomolgus macaque
Stage:Assays Completed
Study Start Date:2012-08-29
Study Made Public:2015-10-19


Linear peptide epitope mapping for two NHP studies (VAC1003 and Schedule 227) using gp140 trimers


CAVD 384 is an immunogenicity study of samples from 2 NHP studies using gp140 trimers.


GLA CN54 gp140 MF59 R848 SF162 TV-1 C

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.